DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,054 filers reported holding DANAHER CORPORATION in Q4 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874,801 | -15.1% | 3,526 | -17.7% | 0.58% | -12.1% |
| Q2 2023 | $1,029,800 | -4.7% | 4,286 | +0.0% | 0.66% | -7.9% |
| Q1 2023 | $1,081,148 | -5.2% | 4,285 | -0.2% | 0.71% | -9.7% |
| Q4 2022 | $1,141,053 | -0.4% | 4,295 | -3.2% | 0.79% | -9.6% |
| Q3 2022 | $1,146,000 | -6.6% | 4,435 | -8.3% | 0.87% | +1.8% |
| Q2 2022 | $1,227,000 | -13.1% | 4,835 | +0.5% | 0.86% | +1.1% |
| Q1 2022 | $1,412,000 | -21.8% | 4,810 | -12.3% | 0.85% | -18.6% |
| Q4 2021 | $1,806,000 | +8.6% | 5,485 | +0.5% | 1.04% | +0.3% |
| Q3 2021 | $1,663,000 | +13.4% | 5,458 | 0.0% | 1.04% | +12.8% |
| Q2 2021 | $1,466,000 | +17.5% | 5,458 | -1.4% | 0.92% | +10.3% |
| Q1 2021 | $1,248,000 | -1.5% | 5,533 | -2.9% | 0.83% | -9.3% |
| Q4 2020 | $1,267,000 | +0.5% | 5,698 | -2.6% | 0.92% | -15.7% |
| Q3 2020 | $1,261,000 | +18.4% | 5,853 | -2.7% | 1.09% | +13.3% |
| Q2 2020 | $1,065,000 | +23.0% | 6,013 | -3.8% | 0.96% | +5.2% |
| Q1 2020 | $866,000 | -11.9% | 6,250 | -2.3% | 0.92% | +8.7% |
| Q4 2019 | $983,000 | – | 6,400 | – | 0.84% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |